|
Market Closed -
Nasdaq
23:00:00 28/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.290 USD | -1.29% |
|
-0.43% | +99.13% |
| 08-24 | Lexicon Pharma Earns $10 Million Milestone Payment from Novo Nordisk | DJ |
| 08-24 | Lexicon Pharmaceuticals Gets $10 Million Novo Nordisk Milestone Payment for LX9851 | MT |
| Market Cap | 1.02B 878M 823M 751M 1.42B 97.39B 1.42B 9.77B 3.81B 49.16B 3.83B 3.74B 163B | P/E 2026 * |
-13.7x | P/E 2027 * | -12.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.02B 878M 823M 751M 1.42B 97.39B 1.42B 9.77B 3.81B 49.16B 3.83B 3.74B 163B | EV / Sales 2026 * |
26.9x | EV / Sales 2027 * | 51.2x |
| Free-Float |
98.45% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Lexicon Pharmaceuticals, Inc.
| 1 day | -1.29% | ||
| 1 week | -0.43% | ||
| Current month | -0.87% | ||
| 1 month | -2.14% | ||
| 3 months | +3.62% | ||
| 6 months | +55.78% | ||
| Current year | +99.13% |
| 1 week | 2.26 |  | 2.36 |
| 1 month | 1.96 | | 2.52 |
| Current year | 1.1 | | 2.68 |
| 1 year | 1.03 | | 2.68 |
| 3 years | 0.28 | | 3.73 |
| 5 years | 0.28 | | 6.33 |
| 10 years | 0.28 | | 19.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Exton
CEO | Chief Executive Officer | 56 | 08/07/2024 |
Scott Coiante
DFI | Director of Finance/CFO | 59 | 02/01/2025 |
Michael Davies
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Barker
CHM | Chairman | 83 | 01/01/2005 |
Ray Debbane
CHM | Chairman | 71 | 27/02/2012 |
| Director/Board Member | 67 | 28/08/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/3/26 A | Fiscal year | Director | 178,624 | 0.0402% | ||
| 6/3/26 A | Fiscal year | Director | 178,624 | 0.0402% | ||
| 6/3/26 A | Fiscal year | Director | 178,624 | 0.0402% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.29% | -0.43% | +99.13% | +23.78% | 1.02B | |
| -1.59% | -3.35% | +64.49% | +98.69% | 69.54B | |
| -1.34% | -0.75% | +48.56% | +90.63% | 64.97B | |
| -8.37% | -12.43% | +0.14% | -15.42% | 25.64B | |
| -2.35% | -5.75% | -12.17% | +448.29% | 25.89B | |
| +0.30% | -0.69% | +63.18% | +11.93% | 26.51B | |
| -0.96% | +10.36% | +278.86% | +438.78% | 20.22B | |
| -0.51% | +0.23% | +33.71% | -18.02% | 19.98B | |
| -1.91% | -4.37% | +13.33% | +531.29% | 15.69B | |
| -1.47% | +0.68% | +43.67% | +145.49% | 13.49B | |
| Average | -1.95% | -1.78% | +63.29% | +175.54% | 28.29B | |
| Weighted average by Cap. | -1.93% | -1.50% | +57.30% | +152.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.95M 32.7M 30.66M 27.99M 52.72M 3.63B 52.89M 364M 142M 1.83B 142M 139M 6.07B | 19.91M 17.16M 16.09M 14.69M 27.67M 1.9B 27.76M 191M 74.47M 961M 74.76M 73.14M 3.19B |
| Net income | -72.44M -62.42M -58.52M -53.42M -101M -6.92B -101M -694M -271M -3.49B -272M -266M -11.59B | -90.96M -78.38M -73.49M -67.09M -126M -8.69B -127M -872M -340M -4.39B -342M -334M -14.55B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | $2.290 | -1.29% | 2,679,263 |
| 27/08/26 | $2.320 | +0.43% | 1,618,340 |
| 26/08/26 | $2.310 | -1.28% | 1,200,274 |
| 25/08/26 | $2.340 | +0.86% | 1,821,248 |
| 24/08/26 | $2.320 | +0.87% | 1,675,637 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXRX Stock
Select your edition
All financial news and data tailored to specific country editions
